mBio

· 6 papers in corpus
2025
doi:10.1128/mbio.02145-25 ·PMID:41170854

An increase in the number of human cases of influenza A/H5N1 infection in the USA has raised concerns about the pandemic potential of the virus. Pre-existing population immunity is a key determinant for risk assessment and pandemic potentia…

2025
doi:10.1128/mbio.00509-25 ·PMID:40525871

This study aims to examine the specific relationships between gut, oral, and vaginal microbiota and the frozen embryo transfer (FET) process. Patients undergoing fertility treatment who met the inclusion criteria were included in this study…

2024
doi:10.1128/mbio.01639-24 ·PMID:39258922

Sooty mangabeys (SMs) are natural hosts of simian immunodeficiency virus (SIV) and do not progress to AIDS despite high viral replication. The main factors involved in the benign nature of this infection are (i) low level of immune activati…

2022
doi:10.1128/mbio.01619-22 ·PMID:35980030

Cervical cancer is the third leading cause of female cancers globally, resulting in more than 300,000 deaths every year. The majority of all cervical cancers are caused by persistent infections with high-risk human papillomaviruses (hrHPV) …

2022
doi:10.1128/mbio.03705-21 ·PMID:35229634

Combinations of direct-acting antivirals are needed to minimize drug resistance mutations and stably suppress replication of RNA viruses. Currently, there are limited therapeutic options against the severe acute respiratory syndrome coronav…

2019
doi:10.1128/mbio.00226-19 ·PMID:30967458

Multidrug resistance (MDR) by bacterial pathogens constitutes a global health crisis, and resistance to treatment displayed by biofilm-associated infections (e.g., cystic fibrosis, surgical sites, and medical implants) only exacerbates a pr…